4-[(4Z)-3-methyl-5-oxo-4-({5-[3-(trifluoromethyl)phenyl]furan-2-yl}methylidene)-4,5-dihydro-1H-pyrazol-1-yl]benzoic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-[(4Z)-3-methyl-5-oxo-4-({5-[3-(trifluoromethyl)phenyl]furan-2-yl}methylidene)-4,5-dihydro-1H-pyrazol-1-yl]benzoic acid
• 英文别名: 4-[(4Z)-3-methyl-5-oxo-4-[[5-[3-(trifluoromethyl)phenyl]furan-2-yl]methylidene]pyrazol-1-yl]benzoic acid
• 化学式: C₂₃H₁₅F₃N₂O₄
• 分子量: 440.4
• InChiKey: SFVRJPWNVAZKMP-UNOMPAQXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  32
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  83.1
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• [EN] COMPOUNDS AND COMPOSITION FOR USE IN THE INHIBITION OF THE LBC-RHOA INTERACTION, IN PARTICULAR FOR THE TREATMENT OF CANCER<br/>[FR] COMPOSÉS ET COMPOSITION POUVANT ÊTRE UTILISÉS POUR INHIBER L'INTÉRACTION LBC-RHOA, EN PARTICULIER POUR LE TRAITEMENT DU CANCER
  申请人：UNIV DEGLI STUDI MODENA E REGGIO EMILIA

  公开号：WO2015028929A1

  公开（公告）日：2015-03-05

  The present invention relates to compounds of formula (III) and/or salts thereof,or compounds of formula (IV) and/or salts thereof for use in the inhibition of the Lbc-RhoA interaction and to the pharmaceutical compositions comprising the same: Formula (III) and Formula (IV). The present invention relates also to compounds of formula (III) and/or salts thereof, or compounds of formula (IV) and/or salts thereof for use in the treatment of cancer and to the pharmaceutical compositions comprising the same.